Time to Separate Persistent From Recurrent Differentiated Thyroid Cancer: Different Conditions With Different Outcomes
نویسندگان
چکیده
منابع مشابه
Reoperation for recurrent/persistent well-differentiated thyroid cancer.
Reoperative surgery in the neck for recurrent/persistent well-differentiated thyroid cancer is associated with increased morbidity compared with primary surgery. Reoperative surgery is technically more challenging because of the presence of scar tissue and disruption of the normal fascial planes and anatomy, which may result in a greater risk of injury to nerves and other vital structures. When...
متن کاملThyroid cancer: different outcomes to chemotherapy according to tumour histology.
IN THE MANAGEMENT of thyroid carcinoma, doxorubicin alone, or in combination with cisplatin , is considered the most active regimen, although it gives unsatisfactory response rates with significant side-effects [1-3]. Epirubicin is endowed with a spectrum of activity similar to doxorubicin and an equivalent response rate with less cardiotoxicity and acute myelosuppres sion [4, 5]. Carboplatin ...
متن کاملRecurrent differentiated thyroid cancer: to cut or burn
The term “relapse carcinoma” is used improperly to indicate either a local or loco-regional relapse or a systematic metastatsis [1]. Local relapse (LR) after thyroidectomy for cancer is “the repetition of the neoplastic lesion in proximity of the previous intervention of excision” [2]. According to Duren [3] relapses of thyroidal carcinoma need to be classified as: local (LR): that may present ...
متن کاملFactors affecting discharge time of well differentiated thyroid cancer patients receiving 131I therapy: Five years’ experience
Introduction:The post-surgical management of patients with differentiated thyroid cancer include ablation of remnant local and distant metastatic tissues with 131I therapy, which accentuates isolation of the patient in order to avoid unnecessary radiation exposure to the care givers, general public and the environment. The duration of isolation is subject to the redu...
متن کاملThyroid hormone replacement one day before 131I therapy in patients with well-differentiated thyroid cancer
Objective: The current study aimed to determine the efficacy of radioiodine-131 (131I) ablation therapy with thyroid hormone replacement one day before 131I administration in patients with well-differentiated thyroid cancer (DTC). Methods: This retrospective study included 29 patients who underwent 131I therapies twice for DTC during 6-12 months. Since all the patients obviously had residual l...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Clinical Endocrinology & Metabolism
سال: 2018
ISSN: 0021-972X,1945-7197
DOI: 10.1210/jc.2018-01383